🚁Proposed Airworthiness Directive for Airbus Helicopters
The FAA proposes to adopt a new airworthiness directive (AD) for certain Airbus Helicopters Model AS 332L2 and EC 225LP helicopters. This proposed AD was prompted by reports of overlengthened and deformed attachment bolts installed on the link of the main gearbox (MGB) suspension bar attachment bracket. This proposed AD would require replacing certain attachment bolts on the MGB suspension bar fittings, inspecting the removed bolts, and reporting the results of this inspection to Airbus Helicopters. The FAA is proposing this AD to address the unsafe condition on these products.
Learn More⚖️Review Notice on Calcium Hypochlorite Duties by USITC
The Commission hereby gives notice that it has instituted reviews pursuant to the Tariff Act of 1930 ("the Act"), as amended, to determine whether revocation of the antidumping and countervailing duty orders on calcium hypochlorite from China would be likely to lead to continuation or recurrence of material injury. Pursuant to the Act, interested parties are requested to respond to this notice by submitting the information specified below to the Commission.
Learn More⚛️Southern Nuclear's License Renewal Application for Hatch Plant Units
The U.S. Nuclear Regulatory Commission (NRC) has received an application for the subsequent renewal of Renewed Facility Operating License Nos. DPR-57 and NPF-5, which authorize Southern Nuclear Operating Company, Inc. (Southern, the applicant) to operate Edwin I. Hatch Nuclear Plant (Hatch), Unit Nos. 1 and 2. The subsequent renewed licenses would authorize the applicant to operate Hatch for an additional 20 years beyond the period specified in each of the current licenses. The current operating licenses for Hatch expire as follows: Unit No. 1 on August 6, 2034, and Unit No. 2 on June 13, 2038.
Learn More⚖️Intertek USA, Inc. Accredited as Commercial Gauger and Laboratory
Notice is hereby given, pursuant to CBP regulations, that Intertek USA, Inc. (Marion, AR), has been approved to gauge petroleum and certain petroleum products and accredited to test petroleum and certain petroleum products for customs purposes for the next three years as of April 25, 2024.
Learn More🚁FAA Issues Airworthiness Directive for Airbus Helicopters
The FAA is adopting a new airworthiness directive (AD) for Airbus Helicopters Model AS350B, AS350BA, AS350B1, AS350B2, AS350B3, AS350D, AS355E, AS355F, AS355F1, AS355F2, AS355N, and AS355NP helicopters. This AD was prompted by a report of a sliding door that was locked in the open position detaching from the helicopter during flight. This AD requires modifying certain upper rail rollers, installing a label on each sliding door, and prohibits installing affected upper rail rollers or a door having an affected upper rail roller. These actions are specified in a European Union Aviation Safety Agency (EASA) AD, which is incorporated by reference. The FAA is issuing this AD to address the unsafe condition on these products.
Learn More📈SEC Approves FINRA and 24X Regulatory Responsibility Allocation Plan
The Securities and Exchange Commission has approved a plan between the Financial Industry Regulatory Authority and 24X National Exchange to allocate regulatory responsibilities. The plan aims to reduce unnecessary regulatory duplication for mutual members, enhancing operational efficiency while ensuring effective oversight of compliance with applicable laws and regulations.
Learn More💊Notice of Controlled Substances Registration for Veranova, L.P.
Veranova, L.P. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More📊USDA Revises Information Collection for Advisory Committees
This notice announces the U.S. Department of Agriculture's (USDA) intention to revise to the currently approved through October 31, 2027, Advisory Committee and Research and Promotion Background Information AD-755 and Supplemental Lists--Agricultural Marketing Service (AMS), Commodity (Research and Promotion and Marketing Order) specific questionnaire. The revised form will be changed to Advisory Committee or Commodity Board Background Information and include the supplemental information that will allow applicants to answer questions in more detail of their foreign citizenship identification (passport number, passport expiration date, and issuing country). In addition, if an applicant is a foreign national, identify if this person resided in the United States (U.S.) for 3 years or more continuous years. The revised form will meet the required U.S. Office of Management and Budget's Statistical Policy Directive No. 15 of standards for maintaining, collecting, and presenting Federal data. The primary objective is to determine the qualifications, suitability and availability of a candidate to serve on advisory committees and/or commodity boards. Lastly, the AD-755 Form and supplemental questionnaire are being digitized to allow applicants to access and complete the application form electronically.
Learn More⚖️Review of Antidumping Duty on Electrolytic Manganese Dioxide from China
The Commission hereby gives notice that it has instituted a review pursuant to the Tariff Act of 1930 ("the Act"), as amended, to determine whether revocation of the antidumping duty order on electrolytic manganese dioxide from China would be likely to lead to continuation or recurrence of material injury. Pursuant to the Act, interested parties are requested to respond to this notice by submitting the information specified below to the Commission.
Learn More⚗️FDA Classification of Anti-Mullerian Hormone Test System
The Food and Drug Administration (FDA, the Agency, or we) is classifying the anti-mullerian hormone test system into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the anti-mullerian hormone test system's classification. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.
Learn More